Clinical trial
Non-Interventional, Prospective Study Of the Evaluation Of Patients Population With ED, Treated With Sildenafil
NCT01108900 is registered in ClinicalTrials.gov with Pfizer's Upjohn has merged with Mylan to form Viatris Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non-Interventional, Prospective Study Of the Evaluation Of Patients Population With ED, Treated With Sildenafil
- Lead sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2010
- Completion date
- October 31, 2011
- Enrollment
- 100 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.